Event

Across the Great Divide: Creating and Managing Cross-Cultural Partnerships

10:15 AM - 11:30 AM on Monday, Apr 22, 2013


Description: The alliance management profession has developed within the biopharma industry from nice-to-have to a necessity for navigating the risk-causing complexity and realizing the intended value within today’s deals. Some of that...
Event

adVENTURES in Academic Partnering

10:30 AM - 11:30 AM on Tuesday, Apr 23, 2013


Description: Pharma's holding tight to its belief that innovative research and major advances in drug discovery often occur within the walls of academia. How can you best collaborate to allow research to...
Event

Biodefense: Lessons Learned and Opportunities for the Future

2:30 PM - 3:30 PM on Monday, Apr 22, 2013


Description: The biodefense sector has evolved considerably since September 11, 2001. Important legislation has provided critical government funding and other support for the research, development and procurement of medical countermeasures for bioterror...
Event

Bridging the Productivity Gap: Big Pharma Strategies for Accessing Early-Stage Innovation

9:00 AM - 10:15 AM on Tuesday, Apr 23, 2013


Description: Big Pharma is continuing to expand its relationships with venture capitalists and start-ups as a means of sourcing early stage innovation and improving R&D productivity. Recently announced strategies include the establishment...
Event

Can You Reap What You Sow? How the Necessity of Acquiring Early-Stage Assets Can Also Be Win-Win

3:45 PM - 5:00 PM on Monday, Apr 22, 2013


Description: How much is the focus on early stage assets driven by necessity or is the opportunity to fill pipelines with external expertise also an attractive opportunity? Can the increased risk be...
Event

Fashion or Innovation?: Learning From Trends in Dealmaking Over the Past Decade

2:30 PM - 3:30 PM on Tuesday, Apr 23, 2013


Description: Dealmaking is a fashion business. As soon as we hear of an innovation in dealmaking, it seems a pack of imitators and extensions follow. Often, as with the sudden increase in...
Event

Finding Innovation in Emerging Markets

10:30 AM - 11:30 AM on Wednesday, Apr 24, 2013


Description: While biotechnology companies and academic institutions in established markets remain important sources of innovation for pharmaceutical companies looking for licensing deals and partnerships, emerging markets are becoming increasingly attractive. This is...
Event

Orphan Drug Development: Normal Rules Don’t Apply

2:30 PM - 3:30 PM on Wednesday, Apr 24, 2013


Description: Building a company focused on orphan drug development is not an easy task. Investors hesitate to invest due to the complexity of the technologies. Diseases are often not widely known. Preclinical...
Event

Partnering for Effective Drug Development: 90% Joy, 100% Misery or 110% Synergy

3:45 PM - 5:00 PM on Tuesday, Apr 23, 2013


Description: Finding and applying synergies among industry, academia, patients and non-profit foundations can significantly minimize the risk of failure and increase the probability of success in drug discovery and development. In...
Event

Using NIH Resources to Help Advance Biomedical Technology and Drug Projects to Industry Adoption

9:00 AM - 10:15 AM on Wednesday, Apr 24, 2013


Description: Biotechnology companies and university researchers urgently need additional funding and research resources to move technologies and therapeutic programs to industry adoption (i.e. investor funding and corporate partnerships). During the last year,...